ESC Cardio Talk
European Society of Cardiology
The ESC podcasts - regular recordings from the European Society of Cardiology.
Hear renowned experts discuss cardiovascular advances relevant to daily practice.
Check here regularly to stay up to date.
You can also be interested in other ESC podcasts: EHRA Cardio Talk, HFA Cardio Talk and ESC TV Today. Check them out!
Hear renowned experts discuss cardiovascular advances relevant to daily practice.
Check here regularly to stay up to date.
You can also be interested in other ESC podcasts: EHRA Cardio Talk, HFA Cardio Talk and ESC TV Today. Check them out!
Episodes
Mentioned books
Dec 15, 2025 • 13min
Journal editorial - Pressure-volume loops and cardiac energetics: finally, is it time to translate historical knowledge to clinical routine?
With Joao Felipe Fernandes, King's College London, London - UK and Debbie Zhao, The University of Auckland, Auckland - New Zealand. Link to European Heart Journal paper Link to European Heart Journal editorial
Dec 8, 2025 • 8min
Journal editorial - Advanced cardiac imaging in primary prevention: the great challenge we have to achieve
With Edoardo Conte, Galeazzi Sant'Ambrogio Hospital IRCCS, Milano - Italy, Daniele Andreini, Galeazzi Sant'Ambrogio Hospital IRCCS, Milan - Italy and Davide Marchetti, Galeazzi Sant'Ambrogio Hospital IRCCS, Milano - Italy. Link to European Heart Journal paper Link to European Heart Journal editorial
Dec 1, 2025 • 7min
Journal editorial - Macrophage leukotriene B4 production sustains inflammation after myocardial infarction
With Marie-Noelle Giraud, Faculty of Science and Medicine, Fribourg - Switzerland and Carolina Balbi, Research Centre for Molecular Biology, University of Zurich - Switzerland. Link to European Heart Journal paper Link to European Heart Journal editorial
Nov 24, 2025 • 7min
Journal editorial - The emerging story of Myval transcatheter heart valve: lessons from the LANDMARK trial
Paolo Springhetti, a Milanese cardiologist specializing in transcatheter valve therapies, joins Marie-Annick Clavel to discuss the LANDMARK trial findings. They dive into the unique sizing advantages of Myval compared to competitors, highlighting impressive hemodynamic outcomes. Sex-specific definitions of patient-prosthesis mismatch (PPM) come under scrutiny, revealing stark differences among valve types. The duo also explores the implications of Myval's low-flow recovery and durability concerns for younger patients, emphasizing the need for long-term studies.
Nov 17, 2025 • 9min
Journal editorial: The dilemma of a correct patient selection for implantable cardioverter defibrillator in non-ischaemic cardiomyopathy
With Domenico Filomena, Polyclinic Umberto I, Rome - Italy and Luciano Agati Sapienza, University of Rome, Rome - Italy. Link to European Heart Journal paper Link to European Heart Journal editorial
Nov 10, 2025 • 11min
Journal editorial: Is routine imaging follow-up after LAA closure necessary?
With Jonathan Lessick, Rambam Health Care Campus, Haifa - Israel and Mahmoud Suleiman, Rambam Health Care Campus, Haifa - Israel. Link to European Heart Journal paper Link to European Heart Journal editorial
Oct 20, 2025 • 11min
Journal Editorial: Perioperative discontinuation of renin–angiotensin system inhibitors in non-cardiac surgery: is it time to change what we tell our patients?
With Maura Marcucci, Clinical Institute Humanitas IRCCS, Rozzano - Italy and McMaster University, Hamilton - Canada and Mauro Chiarito, Clinical Institute Humanitas IRCCS, Rozzano - Italy and Icahn School of Medicine at Mount Sinai, NYC - USA. Link to European Heart Journal paper Link to European Heart Journal editorial
Oct 20, 2025 • 10min
Journal editorial: Arrhythmic risk and advanced heart failure in dilated cardiomyopathy: a deadly tango
With Jean-Benoit Le Polain de Waroux, St-Jan Hospital, Brugge - Belgium, and Maarten De Smet, AZ Sint Jan, Brugge - Belgium. Link to European Heart Journal paper Link to European Heart Journal editorial
Oct 6, 2025 • 13min
Journal editorial: ApoB and Lp(a): core measures to assess cardiovascular risk
Allan Sniderman, a cardiologist and professor at McGill University, dives into the importance of ApoB and Lp(a) for cardiovascular risk assessment. He challenges traditional views on VLDL versus LDL atherogenicity, revealing that VLDL may pose greater risks than previously thought. Sniderman discusses a comprehensive study involving over 200,000 participants, elaborating on how examining particle numbers can change risk interpretations. He advocates for measuring ApoB and Lp(a) to enhance clinical insights and streamline patient care.
Sep 29, 2025 • 12min
Journal editorial: With a little HELP from heparin at first medical contact before primary percutaneous coronary intervention
With David Erlinge and Sasha Koul, Lund University, Lund - Sweden Read the European Heart Journal paper Read the European Heart Journal editorial
